Ryan J. Watts
2017
In 2017, Ryan J. Watts earned a total compensation of $1.4M as President and Chief Executive Officer at Denali Therapeutics, a 125% increase compared to previous year.
Compensation breakdown
| Bonus | $374,688 |
|---|---|
| Option Awards | $497,350 |
| Salary | $481,056 |
| Other | $13,769 |
| Total | $1,366,863 |
Watts received $497.4K in option awards, accounting for 36% of the total pay in 2017.
Watts also received $374.7K in bonus, $481.1K in salary and $13.8K in other compensation.
Rankings
In 2017, Ryan J. Watts' compensation ranked 7,459th out of 14,666 executives tracked by ExecPay. In other words, Watts earned more than 49.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,459 out of 14,666 | 49th |
Division Manufacturing | 2,784 out of 5,772 | 52nd |
Major group Chemicals And Allied Products | 903 out of 2,075 | 57th |
Industry group Drugs | 706 out of 1,731 | 59th |
Industry Biological Products, Except Diagnostic Substances | 135 out of 313 | 57th |
Source: SEC filing on April 26, 2018.
Watts' colleagues
We found three more compensation records of executives who worked with Ryan J. Watts at Denali Therapeutics in 2017.
News
Denali Therapeutics CEO Ryan Watts' 2021 pay jumps 36% to $13M
April 19, 2022
Denali Therapeutics CEO Ryan Watts' 2020 pay jumps 87% to $9.3M
April 22, 2021
Denali Therapeutics CEO Ryan Watts' 2019 pay slips 17% to $5M
April 22, 2020
Denali Therapeutics CEO Ryan Watts' 2018 pay jumps 338% to $6M
April 18, 2019